Lv1
8 积分 2026-05-06 加入
A bispecific CD3×CD19 antibody for systemic lupus erythematosus: a phase 1 trial
48分钟前
待确认
In vivo CAR T cell generation to treat cancer and autoimmune disease
21天前
已完结
Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity
2个月前
已完结
Design and Preclinical Development of a Novel In Vivo Chimeric Antigen Receptor (CAR) Product for B-Cell Involved Diseases
2个月前
已关闭
Molecular, Biologic, and Pharmacokinetic Properties of Monoclonal Antibodies: Impact of These Parameters on Early Clinical Development
2个月前
已完结
An FDA oncology analysis of CD3 bispecific constructs and first-in-human dose selection
2个月前
已完结
Coordinate tumor-antigen uptake and dendritic cell activation by chimeric antigen receptors
2个月前
已完结
Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell–engaging bispecific antibody targeting human claudin 6
3个月前
已完结
Preparation of targeted lipid nanoparticles for precision nucleic acid delivery
4个月前
已完结
Chemical Design Strategy of Ionizable Lipids for In Vivo mRNA Delivery
4个月前
已完结
皖公网安备34019202002308
